In summary, we demonstrate that metastatic breast cancer patients have an increased frequency of circulating KIT+CD11b+ cells, M2-polarized CD11b+ cells and elevated levels of the M2 cytokine IL-10 and CCL20. This evidence concerns the gene IL10 and breast carcinoma.